Graeme K. Rutledge

Corporate Officer/Principal presso Neurochem (International) Ltd.

82 anni

Health Technology

Commercial Services

Posizioni attive di Graeme K. Rutledge

Società	Posizione	Inizio	Fine
Neurochem (International) Ltd. Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Neurochem (International) Ltd. provides licensing and partnering activities. Its services include supply chain management and sales, clinical, and regulatory & marketing functions required to develop products. Neurochem is headquartered in Lausanne, Switzerland.	Corporate Officer/Principal	-	-

Società	Posizione	Inizio	Fine
BELLUS HEALTH	Direttore/Membro del Consiglio	01/01/2003	-

Distribuzione geografica

Canada	2
Svizzera	2

Posizioni

Director/Board Member	1
Corporate Officer/Principal	1

Settori

Health Technology	2
Commercial Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	2
BELLUS Health, Inc. BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.	Health Technology
Neurochem (International) Ltd. Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Neurochem (International) Ltd. provides licensing and partnering activities. Its services include supply chain management and sales, clinical, and regulatory & marketing functions required to develop products. Neurochem is headquartered in Lausanne, Switzerland.	Commercial Services

Aziende private

Health Technology

Commercial Services